Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Professor Lu Yang Explores Latest Advances and Combination Strategies in AR-Targeted Therapy at the 2025 Pujiang Prostate Cancer Congress

    On June 27, 2025, the Pujiang Prostate Cancer Academic Congress was held in Shanghai, in conjunction with the Annual Meeting of the Chinese Society of Clinical Oncology Prostate Cancer Committee (CSCO-PC), the Prostate Cancer Meeting of the CACA Genitourinary Oncology Committee (CACA-GO), and the Annual Meeting of the Chinese Prostate Cancer Consortium (CPCC). The event…

    2025.07.23
  • APACC 2025 Interview Highlight | Professor Joe Jarvis on Confronting the Global Burden of Advanced HIV Disease

    At the Asia-Pacific AIDS & Co-Infections Conference (APACC 2025), Professor Joe Jarvis from the National Institute for Health and Care Research (NIHR) shared urgent perspectives on a critically underserved area—advanced…

    2025.07.22
  • APACC 2025 Interview Highlight | Dr. Junko Tanuma on HIV Control and Syphilis Resurgence

    During the Asia-Pacific AIDS & Co-Infections Conference (APACC 2025) in Tokyo, we had the privilege of speaking with Conference Chair Dr. Junko Tanuma, Professor at the International University of Health…

    2025.07.22
  • APACC Global Perspective丨Professor Joe Jarvis: Challenges and Global Strategies in Advanced HIV Disease Management

    IDF: You described individuals with advanced HIV infection as a ‘neglected disease group’ in your report. What evidence supports this characterization? Which critical findings in World Health Organisation (WHO) reports…

    2025.07.22
  • APACC Global Perspective丨Dr. Benjamin Bavinton: Innovation in HIV PrEP Service Models and Optimization of Promotion Strategies in the Asia-Pacific

    IDF: Could you please give a brief overview of your research focus and current key projects? Dr. Bavinton: My name is Benjamin Bavinton, and I work at the Kirby Institute,…

    2025.07.22
  • APACC Chair Dr. Junko Tanuma: Tackling HIV Control and Syphilis Resurgence Through Global Collaboration

    IDF: As the Conference Chair, could you highlight key agenda innovations? How will Japan facilitate multinational collaboration on HIV and co-infection management across the Asia-Pacific region? Dr. Tanuma: Firstly, I…

    2025.07.22
  • APACC Global Perspective丨Dr. Thomas Fitzpatrick: How the “Pay-It-Forward” Model Enhances DoxyPEP Accessibility among Key Populations

    IDF: In your research conducted in China, how does the Pay-It-Forward mechanism alter the willingness to pay for Doxy-PEP among men who have sex with men (MSM)? Dr. Fitzpatrick: I…

    2025.07.22
  • Professor Dingwei Ye: A “Precision Breakthrough” in Prostate Cancer Prevention and Treatment in China | 2025 Pujiang Prostate Cancer Congress

    As the tides of the Pujiang River surge forward, so too does China’s momentum in prostate cancer innovation. The 2025 Pujiang Prostate Cancer Academic Congress—held jointly with the Annual Meeting of the CSCO Prostate Cancer Committee (CSCO-PC), the Prostate Cancer Conference of the CACA Genitourinary Oncology Committee (CACA-GO), and the Annual Conference of the Chinese…

    2025.07.21
«previous next»
Recent Posts
  • The 14th Lu Daopei Hematology Forum丨Professor Huili Zhu: Evidence-Based Updates and Precision Prevention and Control — A Clinical Interpretation of the 7th Edition of the Guidelines for Invasive Fungal Disease in Hematologic Disorders
  • The 14th Lu Daopei Hematology Forum | Professor Hui Wang: Building the Foundation with Precision Diagnosis, Advancing with Intelligent Empowerment—The Clinical Value and Future Directions of Hematologic Laboratory Testing
  • The 14th Lu Daopei Hematology Forum | Peihua Lu: Fourteen Years of Staying True to the Mission and Embarking on a New Journey—The Value and Future of an Academic Platform for Hematology
  • The 14th Lu Daopei Hematology Forum | Dongchu Wang: Unlocking the Predictive Value of Cytokines and Optimizing the Entire Treatment Pathway—Research and Prospects of CD7 CAR-T as a Bridge to Transplantation
  • The 14th Lu Daopei Hematology Forum | Dr. Shu Yan: Stratified Prevention and Control, Comprehensive Management—Strategies for the Diagnosis and Treatment of Invasive Fungal Disease After Hematopoietic Stem Cell Transplantation
Recent Comments
    Archives
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top